HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Cash from Financing Activities
HLS Therapeutics Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Cash from Financing Activities
-$14.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
-6%
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Cash from Financing Activities
CA$23.9k
|
CAGR 3-Years
-77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
See Also
What is HLS Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
-14.6m
USD
Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Cash from Financing Activities amounts to -14.6m USD.
What is HLS Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-6%
Over the last year, the Cash from Financing Activities growth was -113%.